Woodstock Corp Eye Point Pharmaceuticals, Inc. Transaction History
Woodstock Corp
- $1 Billion
- Q1 2025
A detailed history of Woodstock Corp transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodstock Corp holds 71,480 shares of EYPT stock, worth $490,352. This represents 0.04% of its overall portfolio holdings.
Number of Shares
71,480
Previous 71,480
-0.0%
Holding current value
$490,352
Previous $532,000
21.8%
% of portfolio
0.04%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding EYPT
# of Institutions
161Shares Held
73.1MCall Options Held
187KPut Options Held
225K-
Cormorant Asset Management, LP Boston, MA8.33MShares$57.1 Million4.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.78MShares$46.5 Million2.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$39.4 Million0.08% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$28.4 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.09MShares$28 Million0.05% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $234M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...